title: Term infants with transient tachypnoea
text: |
  Term infants with transient tachypnoea
  |
  bet | 229/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Term infants with transient tachypnoea: Diuretics had no effect in the treatment of transient tachypnoea of the newborn.5 (LOE I, GOR B)
  Preterm infants with respiratory distress (RDS): There are no data to support routine administration of furosemide in preterm infants with RDS and it may increase the risk of developing a symptomatic patent ductus arteriosus.6 (LOE I GOR B)
  Electively transfused preterm infants beyond the first week of life: Furosemide resulted in a reduction in post transfusion FiO2 (0.29 versus 0.27) which may be clinically insignificant.7 (LOE II, GOR C)
  Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants: Use of furosemide in combination with indomethacin increased the incidence of acute renal failure and did not affect the PDA closure rate.8,9 (LOE II, GOR C)
  |
  | |